Headlines about Imperva (NASDAQ:IMPV) have trended somewhat positive on Monday, according to Accern Sentiment. The research firm identifies negative and positive media coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Imperva earned a daily sentiment score of 0.16 on Accern’s scale. Accern also assigned headlines about the software maker an impact score of 46.5232495755056 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

These are some of the headlines that may have effected Accern’s scoring:

Shares of Imperva (NASDAQ:IMPV) opened at $44.25 on Monday. Imperva has a 52 week low of $37.17 and a 52 week high of $52.40. The company has a market cap of $1,510.00, a PE ratio of 163.89 and a beta of 1.78.

Imperva (NASDAQ:IMPV) last posted its quarterly earnings data on Wednesday, November 8th. The software maker reported $0.33 EPS for the quarter, topping the consensus estimate of $0.22 by $0.11. The business had revenue of $83.89 million for the quarter, compared to analyst estimates of $83.79 million. Imperva had a net margin of 3.04% and a negative return on equity of 8.52%. Imperva’s quarterly revenue was up 22.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.08 earnings per share. equities analysts anticipate that Imperva will post -0.52 earnings per share for the current fiscal year.

IMPV has been the topic of a number of research reports. Zacks Investment Research raised shares of Imperva from a “hold” rating to a “strong-buy” rating and set a $50.00 target price on the stock in a research note on Tuesday, October 24th. Wells Fargo & Co lowered shares of Imperva from an “outperform” rating to a “market perform” rating in a research note on Monday, October 9th. Imperial Capital cut their target price on shares of Imperva from $57.00 to $50.00 and set an “outperform” rating on the stock in a research note on Tuesday, October 10th. Piper Jaffray Companies lowered shares of Imperva from an “overweight” rating to a “neutral” rating and set a $42.00 target price on the stock. in a research note on Monday, October 16th. Finally, Morgan Stanley reaffirmed an “underweight” rating and set a $39.00 target price on shares of Imperva in a research note on Thursday, November 9th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and nine have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $51.86.

COPYRIGHT VIOLATION WARNING: “Somewhat Positive Press Coverage Somewhat Unlikely to Impact Imperva (IMPV) Share Price” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright & trademark legislation. The correct version of this report can be read at https://www.thecerbatgem.com/2018/01/15/somewhat-positive-press-coverage-somewhat-unlikely-to-impact-imperva-impv-share-price.html.

Imperva Company Profile

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Insider Buying and Selling by Quarter for Imperva (NASDAQ:IMPV)

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.